Association between multimorbidity status and incident dementia: a prospective cohort study of 245,483 participants

[1]  G. Livingston,et al.  Health conditions linked to heightened risk of Alzheimer's disease. , 2022, The Lancet. Digital health.

[2]  S. Sabia,et al.  Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study , 2022, BMJ.

[3]  S. Lu,et al.  Risk of dementia in colorectal cancer patients receiving chemotherapy: A nationwide cohort study , 2022, Cancer Epidemiology.

[4]  F. K. Chan,et al.  Probiotic supplementation demonstrates therapeutic potential in treating gut dysbiosis and improving neurocognitive function in age-related dementia , 2022, European Journal of Nutrition.

[5]  OUP accepted manuscript , 2022, Brain.

[6]  Hyunseok Kang,et al.  Effect of chemotherapy and radiotherapy on cognitive impairment in colorectal cancer: evidence from Korean National Health Insurance Database Cohort , 2021, Epidemiology and health.

[7]  A. Shin,et al.  Effect of Chemotherapy and Radiotherapy on Cognitive Function in Colorectal Cancer: Evidence from National Representative Longitudinal Database , 2021 .

[8]  Ya-Ting Chang,et al.  Sex Difference in the Risk of Dementia in Patients with Atrial Fibrillation , 2021, Diagnostics.

[9]  F. Mair,et al.  Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort , 2021, Clinical kidney journal.

[10]  C. Sudlow,et al.  Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[11]  D. Greenwood,et al.  Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank participants , 2021, The American journal of clinical nutrition.

[12]  B. Dubois,et al.  Investigating the association between cancer and the risk of dementia: Results from the Memento cohort , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[13]  L. Fratiglioni,et al.  Multimorbidity burden and dementia risk in older adults: The role of inflammation and genetics , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[14]  P. Edison,et al.  Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? , 2020, Nature Reviews Neurology.

[15]  P. Simos,et al.  Cognitive Impairment and Dementia in Primary Care: Current Knowledge and Future Directions Based on Findings From a Large Cross-Sectional Study in Crete, Greece , 2020, Frontiers in Medicine.

[16]  J. Mar,et al.  Incidence of Dementia and Associated Factors in the EPIC-Spain Dementia Cohort. , 2020, Journal of Alzheimer's disease : JAD.

[17]  Youn-Jung Kim,et al.  Effect of Obesity on Cognitive Impairment in Vascular Dementia Rat Model via BDNF-ERK-CREB Pathway , 2020, Biological research for nursing.

[18]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[19]  L. Tan,et al.  Association of body mass index with risk of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies , 2020, Neuroscience & Biobehavioral Reviews.

[20]  I. Porto,et al.  Alzheimer's Disease and Cardiovascular Disease: A Particular Association , 2020, Cardiology research and practice.

[21]  M. Kivimäki,et al.  Respiratory disease and lower pulmonary function as risk factors for dementia: a systematic review with meta-analysis: Pulmonary function and dementia. , 2020, Chest.

[22]  L. Tan,et al.  Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies , 2019, Ageing Research Reviews.

[23]  Nattawut Leelakanok,et al.  Association between polypharmacy and dementia – A systematic review and metaanalysis , 2019, Aging & mental health.

[24]  K. Langa,et al.  Multimorbidity and cognitive decline over 14 years in older Americans. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  Y. Zheng,et al.  Association between osteoarthritis and increased risk of dementia , 2019, Medicine.

[26]  C. Jack,et al.  The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  L. Holmberg,et al.  Androgen deprivation therapy for prostate cancer and risk of dementia , 2019, BJU international.

[28]  A. Roso-Llorach,et al.  Patterns of Multimorbidity in a Population-Based Cohort of Older People: Sociodemographic, Lifestyle, Clinical, and Functional Differences , 2019 .

[29]  L. Fratiglioni,et al.  Atrial fibrillation, antithrombotic treatment, and cognitive aging , 2018, Neurology.

[30]  D. Llewellyn,et al.  Stroke and dementia risk: A systematic review and meta-analysis , 2018, Alzheimer's & Dementia.

[31]  I. Harsch,et al.  Hypoglycemic side effects of sulfonylureas and repaglinide in ageing patients - knowledge and self-management. , 2018, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[32]  Asad Ali,et al.  Does Obesity Increase the Risk of Dementia: A Literature Review , 2018, Cureus.

[33]  Carol Brayne,et al.  Anticholinergic drugs and risk of dementia: case-control study , 2018, BMJ.

[34]  A. Carvalho,et al.  Chronic Physical Conditions, Multimorbidity, and Mild Cognitive Impairment in Low‐ and Middle‐Income Countries , 2018, Journal of the American Geriatrics Society.

[35]  M. Morris,et al.  Androgen‐deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire? , 2018, Cancer.

[36]  M. Fenech,et al.  Homocysteine and Dementia: An International Consensus Statement , 2018, Journal of Alzheimer's disease : JAD.

[37]  A. Kalinkovich,et al.  Hierarchical, imbalanced pro-inflammatory cytokine networks govern the pathogenesis of chronic arthropathies. , 2018, Osteoarthritis and cartilage.

[38]  G. Landreth,et al.  Targeting Neuroinflammation to Treat Alzheimer’s Disease , 2017, CNS Drugs.

[39]  Gillian E. Caughey,et al.  What is polypharmacy? A systematic review of definitions , 2017, BMC Geriatrics.

[40]  Klaus P. Ebmeier,et al.  Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study , 2017, JAMA psychiatry.

[41]  Laura Fratiglioni,et al.  Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  C. Epperson,et al.  Considering sex and gender in Alzheimer disease and other dementias , 2016, Dialogues in clinical neuroscience.

[43]  M. Carrillo,et al.  Research priorities to reduce the global burden of dementia by 2025 , 2016, The Lancet Neurology.

[44]  C. Jack,et al.  Multimorbidity and neuroimaging biomarkers among cognitively normal persons , 2016, Neurology.

[45]  Cheng-Li Lin,et al.  Irritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study , 2016, PloS one.

[46]  Ronald C Petersen,et al.  Multimorbidity and Risk of Mild Cognitive Impairment , 2015, Journal of the American Geriatrics Society.

[47]  Laura Fratiglioni,et al.  A major role for cardiovascular burden in age-related cognitive decline , 2015, Nature Reviews Cardiology.

[48]  A. Vicario,et al.  At the Heart of Brain Disorders - Preventing Cognitive Decline and Dementia. , 2015, European cardiology.

[49]  M. Ganguli.  Cancer and Dementia: It’s Complicated , 2015, Alzheimer disease and associated disorders.

[50]  R. Holle,et al.  A claims data-based comparison of comorbidity in individuals with and without dementia , 2014, BMC Geriatrics.

[51]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[52]  M. Noble,et al.  MEK1/2 Inhibition Suppresses Tamoxifen Toxicity on CNS Glial Progenitor Cells , 2013, The Journal of Neuroscience.

[53]  Carlo Caltagirone,et al.  Inverse occurrence of cancer and Alzheimer disease , 2013, Neurology.

[54]  Xianglin L. Du,et al.  Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer. , 2013, International journal of oncology.

[55]  J. Giedd,et al.  Review: magnetic resonance imaging of male/female differences in human adolescent brain anatomy , 2012, Biology of Sex Differences.

[56]  M. O’Banion,et al.  Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice , 2011, Journal of Neuroinflammation.

[57]  Amy L. Byers,et al.  Depression and risk of developing dementia , 2011, Nature Reviews Neurology.

[58]  B. Stegmayr,et al.  Sex Differences in Stroke Epidemiology: A Systematic Review , 2009, Stroke.

[59]  U. Capitanio,et al.  Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening. , 2008, Journal of Sexual Medicine.

[60]  C. Björkelund,et al.  Midlife respiratory function and Incidence of Alzheimer's disease: A 29-year longitudinal study in women , 2007, Neurobiology of Aging.

[61]  A. Gupta,et al.  THE ASSOCIATION BETWEEN BLOOD COAGULATION MARKERS, ATHEROTHROMBOSIS AND DEMENTIA , 2003, International journal of clinical practice.

[62]  R B D'Agostino,et al.  Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.